X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
proliferative diabetic retinopathy (38) 38
diabetic retinopathy (25) 25
humans (25) 25
index medicus (25) 25
pdr (24) 24
ophthalmology (17) 17
female (15) 15
male (15) 15
middle aged (15) 15
endothelial growth-factor (12) 12
vascular endothelial growth factor (12) 12
diabetes (11) 11
adult (10) 10
aged (9) 9
angiogenesis (8) 8
neovascularization (7) 7
panretinal photocoagulation (7) 7
retina (7) 7
retinopathy (7) 7
vitrectomy (7) 7
bevacizumab (6) 6
diabetic retinopathy - diagnosis (6) 6
eye diseases (6) 6
risk factors (6) 6
analysis (5) 5
diabetes mellitus (5) 5
diabetic retinopathy - metabolism (5) 5
disease (5) 5
endocrinology & metabolism (5) 5
medicine & public health (5) 5
npdr (5) 5
prevalence (5) 5
proliferative vitreoretinopathy (5) 5
vegf (5) 5
visual acuity (5) 5
animals (4) 4
care and treatment (4) 4
complications (4) 4
cytokines (4) 4
diabetic retinopathy - physiopathology (4) 4
diabetics (4) 4
genetic structures (4) 4
intravitreal bevacizumab (4) 4
macular edema (4) 4
retrospective studies (4) 4
vitreous body (4) 4
angiogenesis inhibitors - administration & dosage (3) 3
antibodies, monoclonal - administration & dosage (3) 3
antibodies, monoclonal, humanized (3) 3
avastin (3) 3
diabetes mellitus, type 2 - complications (3) 3
diabetic macular edema (3) 3
diabetic retinopathy - drug therapy (3) 3
diabetic retinopathy - surgery (3) 3
diagnosis (3) 3
disease progression (3) 3
endocrine system diseases (3) 3
enzyme-linked immunosorbent assay (3) 3
expression (3) 3
inflammation (3) 3
injections (3) 3
involvement (3) 3
medicine, research & experimental (3) 3
mellitus (3) 3
nonproliferative diabetic retinopathy (3) 3
pdr, proliferative diabetic retinopathy (3) 3
pharmacology & pharmacy (3) 3
physiology (3) 3
prp (3) 3
reproducibility of results (3) 3
sense organs (3) 3
therapy (3) 3
triamcinolone acetonide (3) 3
vitreous body - metabolism (3) 3
vitreous hemorrhage (3) 3
안과학 (3) 3
4-year incidence (2) 2
age (2) 2
arteriovenous passage time (2) 2
article (2) 2
association (2) 2
biomarkers - metabolism (2) 2
biomedical imaging (2) 2
blindness (2) 2
blood vessels (2) 2
case-control studies (2) 2
cell biology (2) 2
cells (2) 2
chemokines (2) 2
chemotactic protein-1 (2) 2
diabetic retinopathy - blood (2) 2
diabetic retinopathy - complications (2) 2
diabetic retinopathy - epidemiology (2) 2
diabetic retinopathy - genetics (2) 2
diabetic retinopathy - pathology (2) 2
diabetic-retinopathy (2) 2
dme, diabetic macular oedema (2) 2
dr, diabetic retinopathy (2) 2
endothelial growth factors (2) 2
endothelial-cells (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Graefe's Archive for Clinical and Experimental Ophthalmology, ISSN 0721-832X, 12/2008, Volume 246, Issue 12, pp. 1699 - 1705
Journal Article
Cellular Physiology and Biochemistry, ISSN 1015-8987, 11/2014, Volume 34, Issue 5, pp. 1733 - 1740
Background: Diabetic retinopathy (DR) is a retinopathy resulting from diabetes mellitus (DM) which was classified into non-proliferative DR (NPDR) and... 
Original Paper | NPDR | Serum miRNA | Dynamic monitoring | Signature | PDR | DIAGNOSIS | PHYSIOLOGY | MECHANISM | MICRORNAS | CELL BIOLOGY | Dynamic monitoring, signature | PROFILE | PLASMA | GLUCOSE | ENDOTHELIAL-CELLS | DISEASE | Diabetic Retinopathy - blood | Diabetic Retinopathy - diagnosis | Double-Blind Method | Humans | Middle Aged | Female | Male | ROC Curve | MicroRNAs - blood | Biomarkers - blood | Case-Control Studies
Journal Article
Ophthalmology, ISSN 0161-6420, 09/2016, Volume 123, Issue 9, pp. 1919 - 1925
Journal Article
Journal Article
Graefe's Archive for Clinical and Experimental Ophthalmology, ISSN 0721-832X, 8/2017, Volume 255, Issue 8, pp. 1515 - 1523
Journal Article
Pharmacology and Therapeutics, ISSN 0163-7258, 03/2017, Volume 171, pp. 30 - 42
Pericytes are a heterogeneous population of cells located in the blood vessel wall. They were first identified in the 19th century by Rouget, however their... 
Pericytes | Perivascular stem cells | Diabetic retinopathy | Diabetic nephropathy | Pericyte fibrosis | Cancer stem cells | DIABETIC-RETINOPATHY | Cancer stern cells | VEGF-A | BLOOD-BRAIN-BARRIER | MESENCHYMAL STEM-CELLS | EPITHELIUM-DERIVED FACTOR | HIGH GLUCOSE | PHARMACOLOGY & PHARMACY | STROMAL CELLS | TUMOR-GROWTH | GLYCATION END-PRODUCTS | ENDOTHELIAL GROWTH-FACTOR | Neoplasms - therapy | Animals | Diabetes Mellitus - physiopathology | Vascular Diseases - therapy | Diabetes Mellitus - therapy | Humans | Pericytes - cytology | Ischemia - therapy | Vascular Diseases - physiopathology | Ischemia - physiopathology | Molecular Targeted Therapy | Neoplasms - pathology | Blood circulation disorders | Therapeutics | Homeopathy | Materia medica and therapeutics | Impotence | Diabetic nephropathies | T cells | Muscle proteins | Cardiovascular agents | Blood coagulation factor VIII | Interleukins | Chronic kidney failure | Type 1 diabetes | Stem cells | Vascular endothelial growth factor | Mitogens | Protein kinases | Growth factors | UUO, unilateral ureteric obstruction | EGFR, EGF receptor | EMT, epithelial-mesenchymal transition | SFT, solitary fibrous tumour | DAN, diabetic autonomous neuropathy | ECM, extracellular matrix | NRF2, nuclear factor (erythroid-derived 2)-like 2 | IL-6, interleukin 6 | PSC, perivascular stem cell | BBB, blood-brain barrier | SOD, super oxide dismutase | HIF, hypoxia inducible factor | ED, erectile dysfunction | SDF-1, stromal derived factor 1 | RAGE, receptors of AGEs | CKD, chronic kidney disease | MMP, matrix metalloproteinases | MDSC, myeloid-derived suppressor cells | DN, diabetic nephropathy | TGF β, transforming growth factor β | PDL-1, programmed death-ligand 1 | ANG2, angiopoietin-2 | Olmfl3, Olfactomedin-like 3 | VEGF, vascular endothelial growth factor | AGE, Advanced Glycation End-Products | EC, endothelial cells | NG2, neural | R, ischemia-reperfusion | MSC, mesenchymal stromal cell | MF-EGF8, milk fat globule epidermal growth factor VIII | IL-8, interleukin 8 | glial antigen 2 | T1D, type 1 diabetic | PDGFb, platelet-derived growth factor B | MAPK, mitogen-activated protein kinase | PDGFRβ, platelet derived growth factor receptor β | DR, diabetic retinopathy | CNS, blood-retinal barrier | HB-EGF, heparin-binding EGF-like growth factor | HPC, hemangiopericytoma | PDR, proliferative diabetic retinopathy | DME, diabetic macular oedema | GFR, glomerular filtration rate | MI, myocardial infarction | SMA, smooth muscle actin | CSC, cancer stem cell | NPDR, non-proliferative diabetic retinopathy | T2D, type 2 diabetic | ROS, reactive oxygen species | Treg, regulatory T cells | BRB, blood-retina barrier | PKC, protein kinase C | DPN, diabetic peripheral neuropathy | TME, tumour microenvironment | ANG1, angiopoietin-1 | GSC, glioblastoma CSC | iPS, induced pluripotent stem cells | GSI, g-secretase inhibitor | FGF-9, fibroblastic growth factor 9 | PEDF, Pigment Epithelium-Derived Factor
Journal Article
Journal of the College of Physicians and Surgeons Pakistan, ISSN 1022-386X, 12/2018, Volume 28, Issue 12, pp. 923 - 927
Journal Article
Asia-Pacific Journal of Ophthalmology, ISSN 2162-0989, 11/2018, Volume 7, Issue 6, pp. 422 - 426
Journal Article
Retina, ISSN 0275-004X, 10/2008, Volume 28, Issue 9, pp. 1319 - 1324
Purpose: To evaluate the efficacy of intravitreal injection of bevacizumab (Avastin) (IVA) in preventing panretinal photocoagulation (PRP)-induced macular... 
Proliferative diabetic retinopathy (PDR) | Intravitreal bevacizumab (Avastin) | Diabetes | Panretinal photocoagulation (PRP) | Vascular endothelial growth factor | Clinically significant diabetic macular edema (CSDME) | PERSISTENT | panretinal photocoagulation (PRP) | MANAGEMENT | SAFETY | proliferative diabetic retinopathy (PDR) | COHERENCE TOMOGRAPHY FINDINGS | intravitreal bevacizumab (Avastin) | TRIAMCINOLONE ACETONIDE | clinically significant diabetic macular edema (CSDME) | VESSELS | MACULAR EDEMA | INJECTION | vascular endothelial growth factor | OPHTHALMOLOGY | VISUAL DYSFUNCTION | NEOVASCULARIZATION | diabetes | Humans | Middle Aged | Postoperative Complications - prevention & control | Fovea Centralis - pathology | Male | Eyeglasses | Bevacizumab | Diabetic Retinopathy - physiopathology | Antibodies, Monoclonal, Humanized | Vitreous Body | Adult | Female | Retrospective Studies | Laser Coagulation - adverse effects | Macula Lutea - pathology | Postoperative Complications - pathology | Severity of Illness Index | Tomography, Optical Coherence | Macula Lutea - drug effects | Treatment Outcome | Diabetic Retinopathy - surgery | Fovea Centralis - drug effects | Visual Acuity | Preoperative Care | Injections | Vision Disorders - prevention & control | Antibodies, Monoclonal - administration & dosage | Vision Disorders - etiology
Journal Article
Bosnian journal of basic medical sciences, ISSN 1512-8601, 02/2019, Volume 19, Issue 1, pp. 94 - 100
Vascular endothelial growth factor (VEGF) is an important regulator of angiogenesis and has been investigated as a candidate gene in a number of conditions,... 
MEDICINE, RESEARCH & EXPERIMENTAL | T2DM | single nucleotide polymorphism | VEGF | VEGFR- | VARIANT | RETINAL NEOVASCULARIZATION | SNP | GENE | COMPLICATIONS | Vascular endothelial growth factor | proliferative diabetic retinopathy | diabetes | ASSOCIATION | PDR | VEGFR-2
Journal Article
Case Reports in Ophthalmology, ISSN 1663-2699, 11/2016, Volume 7, Issue 3, pp. 517 - 522
Background: We report on a patient with proliferative diabetic retinopathy (PDR) and human immunodeficiency virus (HIV) infection who exhibited extremely... 
Case Report | HIV | Proliferative diabetic retinopathy | Vitrectomy | Human immunodeficiency virus | HAART | Highly active anti-retroviral therapy | PDR
Journal Article
Journal of Diabetes and Its Complications, ISSN 1056-8727, 2017, Volume 31, Issue 5, pp. 864 - 868
Journal Article